NCT03372668

Brief Summary

Massage therapy is a treatment self-reported by those with phantom limb pain (PLP) as moderately to extremely effective, but no research to date has been specifically designed to examine such efficacy or effectiveness in this regard. The investigators propose that massage therapy can affect PLP by applying treatment to the corresponding intact limb for amputees. Theoretical underpinnings of massage and mirror therapy have guided this study's development to address PLP through the development of a novel massage intervention. The proof-of-concept experimental study examines the feasibility and outcomes of a combined massage and mirror therapy treatment for individuals with lower limb phantom limb pain. Phantom pain severity, intensity, and interference were measured with visual analogue scales (collected twice weekly for the study's duration) and the Brief Pain Index (collected 4 total times across 12 weeks) using a single-subject, withdrawal design with three, 4-week study phases. Intervention consisted of twice weekly, 20-minute treatments for four weeks. Tailored treatments addressed individual phantom pain experience as if occurring on the corresponding, non-removed limb. Participants viewed treatment as though it were being applied to the amputated limb. Specific Aim: Determine the extent to which massage therapy applied in combination with mirror therapy to the intact leg of an amputee addresses PLP severity, intensity, and interference. Hypothesis: massage and mirror treatment session(s) focused on an intact limb will have acute and cumulative benefits (more pronounced and lasting) for PLP severity, intensity, and interference. All study activity to occur on Indiana University's IUPUI campus.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2015

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 14, 2017

Completed
Last Updated

January 9, 2018

Status Verified

January 1, 2018

Enrollment Period

8 months

First QC Date

December 8, 2017

Last Update Submit

January 6, 2018

Conditions

Keywords

lower limb amputationPLP

Outcome Measures

Primary Outcomes (1)

  • PLP Severity

    PLP severity is measured via visual analogue scales (VAS) of current, average, and worst PLP over the past 2-3 days. Each VAS is a 10cm line with the 10cm end-point indicating "worst pain imaginable" and the 0cm end-point indicating "no pain"

    VAS scores were collected twice weekly (25 times total) throughout the three month study period. Participants were asked to consider the last 2-3 days for the "average" and "worst" VAS and in the moment for the "current" VAS

Secondary Outcomes (3)

  • PLP Intensity and Interference

    Participants complete the BPI four times, once at the beginning and/or end of each 4-week study period. The BPI's recall period is one week.

  • Health Related Quality of Life

    Participants complete the SF36v2 four times, once at the beginning and/or end of each 4-week study period. The SF36vs's recall period is the past four weeks.

  • Perceived Benefit

    Participants were asked about their perceived treatment benefit twice, at the end of the second and third 4-week study period.

Study Arms (1)

All Participants

OTHER

Each study participant will progress through the three, 4-week study periods in the ABA withdrawal design in the same, designated order. The first and third 4-week study periods (or the A periods) have no intervention and only consist of twice weekly data collection. The second 4-week study period (or the B period) will include the twice weekly delivered massage therapy combined with components of mirror therapy intervention.

Other: massage therapy combined with components of mirror therapy

Interventions

Individualized 20-minute, Swedish massage to address participant's unique phantom limb pain experience as if occurring on the corresponding, non-amputated limb. A specially designed apparatus is positioned such that a fixed, real-time image in place of the amputated limb is viewed by the participant during the massage session. The apparatus has a mirror, masking material to hide therapist and participant's lower body, electronic video display, electronic video camera, and equipment to electronically communicate the video signal to the video display. The mirror and video camera positioned to "see" a reflection of the existing limb being massage feds the image to a live video display situated in front of the participant to the correct orientation naturally represent the missing limb.

All Participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ability to understand verbal or written English
  • single limb/appendage, lower limb amputation
  • persistent PLP for at least 1 year
  • routinely has at least 3 occurrences of PLP per week
  • PLP is greater than mild in pain severity according to the pain intensity component of the Brief Pain Inventory (3 or greater out of 10)

You may not qualify if:

  • presence of mild or greater traumatic brain injury
  • known uncontrolled systemic diseases
  • skin issues incompatible with massage application in the area for massage application (open or persistent wounds, fragile skin, etc)
  • mental psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Phantom Limb

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPain

Study Officials

  • Niki Munk, PhD

    Indiana University School of Health & Rehabilitation Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Repeated measures, single-subject withdrawal design with three, 4-week study phases; also referred to as an ABA withdrawal design. Study intervention consisted of twice weekly, 20-minute treatments for four weeks (8 total treatments) and is delivered during the second 4-week study phase. All subjects who enroll in the study will receive the intervention during the second 4-week study phase. There is no randomization.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 8, 2017

First Posted

December 14, 2017

Study Start

August 15, 2014

Primary Completion

March 31, 2015

Study Completion

March 31, 2015

Last Updated

January 9, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be shared upon request. Sharing requests for IPD not included in current publications will be granted as long as secondary or further analyses are not compromised. All sharing requests should be made to the study PI.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
IPD will be available for sharing 3 months after publication. Supporting Information items are available at and after publication submissions.
Access Criteria
The study PI will process and administer IPD and supporting material access via email: nmunk@iu.edu